GCK and type 2 diabetes mellitus: Inactivating GCK mutations lead to maturity-onset diabetes of the young and neonatal diabetes [5]–[7], whereas activating GCK mutations cause persistent hyperinsulinaemic hypoglycaemia [8]–[11].